DIN/PIN Detail - 00754129

280000   CENTRAL NERVOUS SYSTEM AGENTS
281600   PSYCHOTHERAPEUTIC AGENTS
281604   ANTIDEPRESSANTS
28160428   TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS

ELAVIL 75 MG ORAL TABLET

(AMITRIPTYLINE HCL)

Date Listed/Coverage Update:
01-JAN-1992
Date Discontinued:
N/A
Unit Price: 0.3634
LCA or MAC Price:
0.3634
Unit of Issue: Tablet
Interchangeable Products:
YES
Manufacturer:
AA PHARMA INC.
ATC:
N06AA09
Provincial Drug Schedule:**
1
Coverage Status:
REGULAR BENEFIT
Applies to Clients of:
Non-Group Coverage (Group 1)
Coverage for Seniors (Group 66)
Palliative Coverage (Group 20514, Please note:Your client may have Group 1 or Group 66 coverage)
Child and Family Services (Group 20403)
Alberta Child Health Benefit (Group 20400)
Children and Youth Services (Group 19824)
Income Support (Group 19823)
Learners Program (Group 22128)
Alberta Human Services (AISH) (Group 19823)
Alberta Adult Health Benefit (AAHB) (Group 23609)
Coverage Criteria:

N/A

Special Authorization Request Form: N/A
** A drug classification system corresponding to terms of sale. Click here for more information.

To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.